Issues: Vax Specific

Anthrax

Hepatitis B

Hib 

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Pneumococcal    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2015 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

 

Components of
MMR Vaccine
Excipients Table
Allergens Table
Components Table
 

Indication

Immunization against mumps, rubella, and measles

Proprietary Name

MMR II

Manufacturers

Merck

Viability

Live, attenuated

Microorganism

Measles, Mumps, Rubella

Dose

0.5 mL

Route

Subcutaneous

Dose form

Powder

Appearance

When reconstituted, clear yellow.

Concentration (per 0.5 mL)

Measles virus, ≥1000 TCID50

Mumps virus, 12,500 TCID50

Rubella, 1000 TCID50

Preservatives

None

Adjuvants

None

Excipients

Sorbitol, 14.5 mg

Sodium phosphate, sucrose, 1.9 mg

Sodium chloride, hydrolyzed gelatin, 14.5 mg

Recombinant human albumin, ≤0.3 mg

Fetal bovine serum, <1 ppm

Other buffer and media ingredients

Neomycin, 25 mcg

Allergens

Residual egg proteins,

Neomycin, 25 mcg

Media

Measles and Mumps: Medium 199

Rubella: MEM (Minimum Essential Medium)

Packaging

Single-dose vials, vials + diluent, 10-dose vials

Routine Storage

2 to 8 C (36-46 F)

Do Not Freeze

updated June 2014

 

This page was last updated on February 05, 2015

2015 Institute for Vaccine Safety